At least 7,500 measles cases in the U.S. in 2026 priced at 15.5% on Polymarket, down 7.0 points, on $220K traded

Polymarket’s contract on whether the U.S. will record at least 7,500 measles cases in 2026 was priced at 15.5%, down 7.0 percentage points, with $220K traded, in the supplied market update published Oct 25, 2026, at 9:39 PM ET.

The figures indicate a lower market-implied probability of reaching that threshold. They do not establish a change in reported measles cases, and the supplied material contains no updated case count.

Repricing without a confirmed catalyst

According to predictionbubbles.net, its market-movers rankings measure probability-point changes over 24 hours using prices from Polymarket and Kalshi. The supplied page lists a venue-data timestamp of 26 Oct 2026, 01:05 UTC and says its data refresh every 15 minutes.

The accompanying news-search summary identified no significant new platform headline in the preceding 30 minutes. It reported that search results repeated previously reviewed or excluded material, leaving no fresh reporting in the supplied evidence that explains the measles contract’s decline.

Reading the trading figures

Predictionbubbles.net distinguishes price movement from trading activity: its movers rankings depend on the size of the probability-point change, not volume. The $220K traded figure provides context, but the supplied headline does not specify its measurement period or give order-book depth.

The source excerpt also does not include the measles contract’s detailed listing or settlement rules. That limits what can be concluded beyond the reported price, decline and traded amount.

What it means for prediction markets

• The threshold matters: The contract concerns at least 7,500 U.S. measles cases in 2026, not whether cases rise or fall more generally.
• The move is measured in points: The reported decline is 7.0 percentage points, not a 7.0% relative decrease.
• The cause remains unverified: Neither a new case count nor a fresh public-health development is supplied to explain the repricing.
• Volume is not liquidity: The $220K traded figure alone does not show how much trading drove the decline or how readily orders could be filled.